Capricor Therapeutics
CAPR
#7976
Rank
S$0.37 B
Marketcap
S$8.24
Share price
-4.36%
Change (1 day)
-59.22%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.10 Billion

According to Capricor Therapeutics 's latest financial reports the company has S$0.10 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.19 B562.39%
2023-12-31$S$29.84 M88.92%
2022-12-31$S$15.8 M-62.74%
2021-12-31$S$42.4 M13.67%
2020-12-31$S$37.3 M304.6%
2019-12-31$S$9.22 M46.23%
2018-12-31$S$6.3 M-58.01%
2017-12-31$S$15.01 M-359.17%
2016-12-31$-S$5.8 Million296.98%
2015-12-31$-S$1.46 Million-82.32%
2014-12-31$-S$8.26 Million1118.37%
2013-12-31$-S$0.68 Million-111.32%
2012-12-31$S$5.98 M456.35%
2011-12-31$S$1.07 M-67.84%
2010-12-31$S$3.34 M-20.1%
2009-12-31$S$4.18 M-42.64%
2008-12-31$S$7.29 M-66.63%
2007-12-31$S$21.87 M-10683.47%
2006-12-31$-S$0.21 Million59.91%
2005-12-31$-S$0.13 Million34.82%
2004-12-31$-S$0.1 Million38.68%
2003-12-31$-S$0.07 Million62.41%
2002-12-31$-S$0.05 Million157.12%
2001-12-31$-S$0.02 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Cytokinetics
CYTK
-S$0.68 Billion-721.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$8.28 Million-107.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$102.75 B 94,426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$3.89 B 3,481.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$0.77 B 613.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$4.62 M-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA